Smith And Nephew
Smith & Nephew announced the closing of the acquisition of privately-held Kalypto Medical Inc. The acquisition helps bolster Smith & Nephew's Negative Pressure Wound Therapy portfolio. Kalypto Medical makes the NPD 1000, a portable, ambulatory NPWT system. Terms of the deal were not disclosed.
Now that the Food & Drug Administration has approved Smith and Nephew's PICO device for the treatment of wounds, the firm is hoping the pocket-sized device delivers a big payoff. The portable single-use negative pressure wound therapy system consists of a disposable, one-button pump, attached to a dressing which allows for fluid to be absorbed through the dressing. Canisters are not needed and the dressing can be worn up to seven days.